ArticlebioRxiv : the preprint server for biology2026
Structure-guided analysis and prediction of human E2-E3 ligase pairing specificity.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Protein ubiquitination, directed by specific E3 ligases, constitutes the primary cellular pathway for selective protein degradation. In addition to targeting proteins for degradation, ubiquitination can mediate new protein-protein interactions, and otherwise modulate protein function, thereby regulating key cellular processes such as DNA repair and immune responses. Recently, Proteolysis-Targeting Chimeras (PROTACs), and related proximity-inducing agents, have revealed the significant therapeutic potential of co-opting ubiquitin ligase activity to induce the selective degradation of disease-relevant proteins. Despite the biological and clinical significance of this pathway, fundamental gaps remain in our understanding of ubiquitination networks, particularly regarding the specificity of E2-E3 interactions and their substrate preferences. In this study, we leverage analysis of experimental structures in the Protein Data Bank (PDB) and use AlphaFold to generate structures of thousands of ubiquitin-E2-E3 ternary complexes. Using these predicted structures and complementary analyses, we develop a machine learning model to predict functional E2-E3 pairings, advancing our ability to map ubiquitination networks and providing structural insights into functional ubiquitin-E2-E3 complexes. We demonstrate the utility of our model by predicting E2 partners for 88 putative E3 ligases lacking any previously known E2 interactors. Notably, we identify a predicted pairing between UBE2C and RNF214, two proteins recently implicated in hepatocellular carcinoma separately but through interrelated pathways, suggesting a potential functional link mediated by RNF214-dependent ubiquitination in partnership with UBE2C. Additionally, we present our web-resource, UbiqCore, making the E2-E3 pairing predictions and ternary complex structures available to the scientific community (https://dunbrack.fccc.edu/ubiqcore).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.